Literature DB >> 2280581

[Hemodynamic effects of disopyramide on postischemic and normal myocardium].

H M Hoffmeister1, H P Hörmann, M Beyer, L Seipel.   

Abstract

The acute effects of i.v. disopyramide (1.5 mg/kg) on the hemodynamics of postischemic hearts were investigated in comparison to normal ventricles. Infusion (7 min) was started in rats 20 min after 3 x 4 min of global ischemia during the period of stable postischemic dysfunction. 15 minutes after disopyramide i.v. (vs. NaCl control data) the cardiac output was reduced to 82 +/- 4% (vs. 101 +/- 5%; p less than 0.01) and dp/dtmax to 77 +/- 5% (vs. 83 +/- 3%). The maximum isovolumic pressure generating capacity as load-independent index of myocardial contractility was reduced to 89 +/- 2% (vs. 95 +/- 2%; p less than 0.05). In contrast to the results on postischemic myocardium no measureable change of the hemodynamics was detectable after the identical dose in normal animals without left ventricular dysfunction. Our results indicate an increased sensitivity of postischemic myocardium with modestly reduced contractile function to the hemodynamic effects of disopyramide, especially to the negative-inotropic effects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2280581     DOI: 10.1007/bf01815275

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  22 in total

1.  Congestive heart failure after acute myocardial infarction in patients receiving antiarrhythmic agents for ventricular premature complexes (Cardiac Arrhythmia Pilot Study).

Authors:  H L Greene; D W Richardson; A P Hallstrom; R McBride; R J Capone; A H Barker; D M Roden; D S Echt
Journal:  Am J Cardiol       Date:  1989-02-15       Impact factor: 2.778

2.  [Chronotropic action of urethane narcosis on the mouse heart].

Authors:  E Lehr; P E Haeser; G Werner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

Review 3.  Antiarrhythmic drug effects on left ventricular performance.

Authors:  J P Bourke; J C Cowan; S Tansuphaswadikul; R W Campbell
Journal:  Eur Heart J       Date:  1987-03       Impact factor: 29.983

4.  The cardiac effects of d- and l-disopyramide in normal subjects: a noninvasive study.

Authors:  C Pollick; K M Giacomini; T F Blaschke; W L Nelson; K Turner-Tamiyasu; V Briskin; R L Popp
Journal:  Circulation       Date:  1982-08       Impact factor: 29.690

5.  Congestive heart failure caused by oral disopyramide.

Authors:  P J Podrid; A Schoeneberger; B Lown
Journal:  N Engl J Med       Date:  1980-03-13       Impact factor: 91.245

6.  Hemodynamic and electrocardiographic effects of disopyramide in patients with ventricular arrhythmia.

Authors:  J Hulting; G Rosenhamer
Journal:  Acta Med Scand       Date:  1976

7.  Effects of changes in preload, afterload and inotropic state on ejection and isovolumic phase measures of contractility in the conscious dog.

Authors:  F Mahler; J Ross; R A O'Rourke; J W Covell
Journal:  Am J Cardiol       Date:  1975-05       Impact factor: 2.778

8.  Adverse hemodynamic effects of intravenous disopyramide compared with quinidine in conscious dogs.

Authors:  R A Walsh; L D Horwitz
Journal:  Circulation       Date:  1979-11       Impact factor: 29.690

9.  A study of the acute electrophysiological and cardiovascular action of disopyramide in man.

Authors:  P K Marrott; M S Ruttley; J T Winterbottam; J R Muir
Journal:  Eur J Cardiol       Date:  1976-09

10.  High-energy phosphates, myocardial contractile function and material properties after short periods of oxygen deficiency.

Authors:  H M Hoffmeister; R Storf; K U Thiedemann; L Seipel
Journal:  Basic Res Cardiol       Date:  1989 Jan-Feb       Impact factor: 17.165

View more
  1 in total

1.  Effects of the Na+ antagonist cibenzoline on left ventricular function of postischemic hearts.

Authors:  H M Hoffmeister; M E Beyer; L Seipel
Journal:  Cardiovasc Drugs Ther       Date:  1995-04       Impact factor: 3.727

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.